Abstract
Central hyperthermia occurs due to lesions in the thermoregulatory center caused by brain injury or stroke; however, it is uncommon in demyelinating diseases. It is known to poorly respond to antipyretics, and its occurrence is associated with a poor prognosis. While there is no established treatment for central hyperthermia, recent reports highlight successful management with bromocriptine. We present a case of hyperthermia arising from lesions in the medulla in a patient with aquaporin 4 antibody positive neuromyelitis optica spectrum disorder.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
